122 related articles for article (PubMed ID: 6715935)
1. [Study on follow-up procedure for postmolar patients].
Endo N; Kobayashi O; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):531-8. PubMed ID: 6715935
[TBL] [Abstract][Full Text] [Related]
2. [On the follow up period of postmolar patient (author's transl)].
Hando T; Maruyama S; Watanabe S; Hirogami T; Obata N; Kanazawa K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):287-91. PubMed ID: 7069243
[TBL] [Abstract][Full Text] [Related]
3. [Result of registration and follow-up system of gestational trophoblastic disease in Shizuoka Prefecture (from 1977 to 1988)--recent trend and choriocarcinoma following term gestation].
Maeda M; Sugimura M; Kobayashi T; Terao T; Kawashima Y; Sabashi Y; Nakajima K; Uchida T; Nagano T; Kohda M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1921-8. PubMed ID: 2556485
[TBL] [Abstract][Full Text] [Related]
4. Development of postmolar trophoblastic disease after partial molar pregnancy.
Goto S; Yamada A; Ishizuka T; Tomoda Y
Gynecol Oncol; 1993 Feb; 48(2):165-70. PubMed ID: 8428686
[TBL] [Abstract][Full Text] [Related]
5. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
7. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
8. [New trends in trophoblastic disease].
Obata N
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1582-7. PubMed ID: 2543315
[TBL] [Abstract][Full Text] [Related]
9. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
10. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
11. [On the results of hydatidiform mole managed by Niigata method].
Hando T; Kodama S; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2722-30. PubMed ID: 4086902
[TBL] [Abstract][Full Text] [Related]
12. Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience.
Sekharan PK; Sreedevi NS; Radhadevi VP; Beegam R; Raghavan J; Guhan B
J Reprod Med; 2006 Oct; 51(10):835-40. PubMed ID: 17086813
[TBL] [Abstract][Full Text] [Related]
13. [The excretion of chorionic gonadetropin in 55 cases of hydatidiform mole (author's transl)].
Lichtenegger W; Weiss PA
Geburtshilfe Frauenheilkd; 1977 Apr; 37(4):334-7. PubMed ID: 192629
[TBL] [Abstract][Full Text] [Related]
14. [Statistical analysis of trophoblastic disease in Kanagawa prefecture].
Iwata Y; Amemiya K; Uchida K; Okajima H; Kuramoto H; Kenjo T; Koshimizu T; Kosuge O; Gotoda Y; Saito M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):48-54. PubMed ID: 2538525
[TBL] [Abstract][Full Text] [Related]
15. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease.
Kaneki E; Kobayashi H; Hirakawa T; Matsuda T; Kato H; Wake N
Cancer Sci; 2010 Jul; 101(7):1717-21. PubMed ID: 20518791
[TBL] [Abstract][Full Text] [Related]
16. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiologic and clinicopathologic studies of partial hydatidiform mole].
Kodama A; Kanazawa K; Honma S; Aoki Y; Tanaka K; Takahashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1219-25. PubMed ID: 1919183
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of women with recurrent molar pregnancies.
Lorigan PC; Sharma S; Bright N; Coleman RE; Hancock BW
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):288-92. PubMed ID: 10985882
[TBL] [Abstract][Full Text] [Related]
19. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
Shimizu T; Matsuura S; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and postmolar trophoblastic disease.
Berkowitz RS; Goldstein DP; Marean AR; Bernstein M
Obstet Gynecol; 1981 Oct; 58(4):474-7. PubMed ID: 6269038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
